Bo Wu

1.7k total citations
73 papers, 1.3k citations indexed

About

Bo Wu is a scholar working on Molecular Biology, Surgery and Biomaterials. According to data from OpenAlex, Bo Wu has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 18 papers in Surgery and 11 papers in Biomaterials. Recurrent topics in Bo Wu's work include Muscle Physiology and Disorders (23 papers), RNA Interference and Gene Delivery (18 papers) and Thyroid and Parathyroid Surgery (14 papers). Bo Wu is often cited by papers focused on Muscle Physiology and Disorders (23 papers), RNA Interference and Gene Delivery (18 papers) and Thyroid and Parathyroid Surgery (14 papers). Bo Wu collaborates with scholars based in United States, China and Ethiopia. Bo Wu's co-authors include Peijuan Lu, Qi Long Lu, Timothy J. Doran, Mingxing Wang, Caryn Cloer, Qilong Lu, Sapana N. Shah, Hong M. Moulton, Youben Fan and Yongfu Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Bo Wu

66 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Wu United States 20 964 237 191 145 131 73 1.3k
Regina Fritsche‐Danielson Sweden 16 561 0.6× 113 0.5× 260 1.4× 75 0.5× 113 0.9× 25 1.1k
Shoshan Knaän‐Shanzer Netherlands 22 690 0.7× 303 1.3× 343 1.8× 317 2.2× 76 0.6× 34 1.3k
R. Michael Gower United States 16 324 0.3× 121 0.5× 245 1.3× 39 0.3× 112 0.9× 24 1.2k
Yubin Shi United States 8 311 0.3× 97 0.4× 248 1.3× 124 0.9× 105 0.8× 11 1.1k
Liang Chang China 21 849 0.9× 99 0.4× 86 0.5× 50 0.3× 59 0.5× 58 1.4k
Qi Guo China 23 1.2k 1.2× 63 0.3× 134 0.7× 121 0.8× 119 0.9× 65 1.8k
Zhenqi Shi United States 14 944 1.0× 109 0.5× 121 0.6× 151 1.0× 91 0.7× 22 1.6k
Vimal Kishor Singh India 16 633 0.7× 84 0.4× 288 1.5× 306 2.1× 94 0.7× 29 1.2k
Ensiyeh Hajizadeh‐Saffar Iran 17 318 0.3× 132 0.6× 295 1.5× 148 1.0× 62 0.5× 38 861
Alain van Mil Netherlands 21 1.1k 1.2× 48 0.2× 300 1.6× 53 0.4× 184 1.4× 42 1.7k

Countries citing papers authored by Bo Wu

Since Specialization
Citations

This map shows the geographic impact of Bo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wu more than expected).

Fields of papers citing papers by Bo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wu. The network helps show where Bo Wu may publish in the future.

Co-authorship network of co-authors of Bo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Wu. A scholar is included among the top collaborators of Bo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Wu. Bo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Bo, et al.. (2025). Ribitol treatment rescues dystroglycanopathy mice with common L276I mutation. PLoS ONE. 20(8). e0325239–e0325239.
3.
Sang, Tian, Xianzhao Deng, Bomin Guo, et al.. (2024). An automatic parathyroid recognition and segmentation model based on deep learning of near‐infrared autofluorescence imaging. Cancer Medicine. 13(4). e7065–e7065. 3 indexed citations
4.
Zhang, Xiaoping, Yong Zhong, Lin Liu, et al.. (2023). Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma. Cell Death and Disease. 14(12). 78–80. 7 indexed citations
5.
Zhang, Yingchao, Xianzhao Deng, Jie Kang, et al.. (2021). Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer. Medicine. 100(12). e25191–e25191. 13 indexed citations
6.
7.
Wang, Mingxing, et al.. (2020). Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo. Journal of Nanobiotechnology. 18(1). 34–34. 4 indexed citations
8.
Yang, Yajun, Ke Wang, Bo Wu, et al.. (2020). Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(21). 127508–127508. 4 indexed citations
9.
Li, Haonan, Keguang Cheng, Bo Wu, et al.. (2020). Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification. European Journal of Medicinal Chemistry. 210. 113092–113092. 17 indexed citations
10.
Shan, Haojie, et al.. (2019). Risk factors of metastasis to the lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma. European Archives of Oto-Rhino-Laryngology. 277(3). 881–886. 8 indexed citations
11.
Hanna, Nawar, Matthew Wszolek, Amirkasra Mojtahed, et al.. (2019). MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER. The Journal of Urology. 1 indexed citations
12.
Wang, Mingxing, Bo Wu, Sapana N. Shah, Peijuan Lu, & Qilong Lu. (2018). Saponins enhance exon skipping of 2′-O-methyl phosphorothioate oligonucleotide in vitro and in vivo. Drug Design Development and Therapy. Volume 12. 3705–3715. 6 indexed citations
13.
Sun, Bin, Bin Guo, Bo Wu, et al.. (2017). Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016. Osteoporosis International. 29(3). 635–642. 25 indexed citations
14.
Wang, Mingxing, et al.. (2017). Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In Vitro and in mdx Mice. Molecular Therapy — Nucleic Acids. 9. 120–131. 3 indexed citations
15.
Awano, Hiroyuki, et al.. (2016). Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice. PLoS ONE. 11(10). e0164187–e0164187. 13 indexed citations
16.
Awano, Hiroyuki, et al.. (2015). Dystroglycanopathy muscles lacking functional glycosylation of alpha-dystroglycan retain regeneration capacity. Neuromuscular Disorders. 25(6). 474–484. 6 indexed citations
17.
Du, Qiang, et al.. (2013). Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis. Current Medical Research and Opinion. 29(11). 1487–1494. 17 indexed citations
18.
Fan, Youben, Bo Wu, Jie Kang, et al.. (2011). Trans-areola single-site endoscopic thyroidectomy: pilot study of 35 cases. Surgical Endoscopy. 26(4). 939–947. 16 indexed citations
19.
Wu, Bo, et al.. (2011). Targeted Skipping of Human Dystrophin Exons in Transgenic Mouse Model Systemically for Antisense Drug Development. PLoS ONE. 6(5). e19906–e19906. 15 indexed citations
20.
Wu, Bo, Bin Xiao, Caryn Cloer, et al.. (2010). One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice. Molecular Therapy. 19(3). 576–583. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regina Fritsche‐Danielson Breakdown of academic impact, for papers by Shoshan Knaän‐Shanzer Breakdown of academic impact, for papers by R. Michael Gower Breakdown of academic impact, for papers by Yubin Shi Breakdown of academic impact, for papers by Liang Chang Breakdown of academic impact, for papers by Qi Guo Breakdown of academic impact, for papers by Zhenqi Shi Breakdown of academic impact, for papers by Vimal Kishor Singh Breakdown of academic impact, for papers by Ensiyeh Hajizadeh‐Saffar Breakdown of academic impact, for papers by Alain van Mil
Rankless by CCL
2026